K2 HealthVentures Equity Trust LLC 13D and 13G filings for Alto Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:40 pm Sale | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | K2 HealthVentures Equity Trust LLC | 788,995 2.400% | -828,860 (-51.23%) | Filing |
| 2025-05-15 3:19 pm Purchase | 2025-01-13 | 13G | ALTO NEUROSCIENCE INC ANRO | K2 HealthVentures Equity Trust LLC | 1,617,855 5.600% | 1,617,855 (New Position) | Filing |